Header
PROGRAM
 
Search Website
GO
11th COGNO Annual Scientific Meeting
Targeting survival: living well with brain cancer in the era of precision treatments

Sunday 7th October - Tuesday 9th October 2018
Brisbane Convention & Exhibition Centre, Queensland, Australia
 
 
PROGRAM OF EVENTS (2 Oct 2018)
(Changes may be made to the program)
 
To download a printable version, please click here.
 

Sunday 7 October: Pre–ASM Meeting

TIME

MEETING

CHAIR

12:45 – 1:45pm

Brain Cancer Biobanking Australia (BCBA) clinical registry working group (closed meeting) (P9 Room)

Anna Nowak

2:15 – 4:15pm

Brain Cancer Biobanking Australia (BCBA) consortium meeting (closed meeting) (P9 Room)

Anna Nowak

4:30 – 6:00pm

Management Committee (MC) meeting (closed meeting) (P7 Room)

Anna Nowak

6:30pm

Convenor’s Dinner (by invitation only)

 


Monday 8 October: ASM Day 1 (P10&11 Room)

TIME

MEETING

CHAIR

8:00 – 10:00am

COGNO Scientific Advisory Committee Meeting (open to COGNO members only) (P9 Room)

Liz Hovey

10:00 – 10:30am

Morning Tea

 

10:30 – 10:40am

Welcome and Day 1 program overview

Mark Pinkham

10:40 – 12:40pm

Session 1: Opening Plenaries 1-3

Anna Nowak and Mark Pinkham

 

Plenary 1: Challenges in Testing Immunotherapies in Brain Tumor Clinical Trials: Mark Gilbert

 

 

Plenary 2: Developments in Radiation Therapy for Malignant Gliomas: Erik Sulman

 

 

Plenary 3: Patient-Centered Research in Neuro-Oncology: Improving Understanding of the Impact of CNS Tumours and Treatment: Terri Armstrong

 

12:40 – 1:40pm

Lunch

 

1:40 – 3:00pm

Session 2: Brain Metastasis

Matthew Foote

 

Optimal sequencing of radiosurgery and systemic therapy for brain metastases: Mark Pinkham

 

 

Systemic therapies for melanoma brain metastases: Victoria Atkinson

 

 

Systemic therapies for lung cancer brain metastases: Chee Lee

 

 

Trials in Brain Metastasis: Erik Sulman

 

 

Paper ID O01: Developing a targeted therapeutic for brain metastases: Sarah Shigdar

 

 

Paper ID O02: Is volume more relevant than number of metastases? A review of patients treated with Gamma Knife in Australia between 2010 and 2017: Michael Izard

 

 

Paper ID O03: Proteomic analysis of breast cancer brain metastasis microenvironment in-vivo reveals a unique milieu intérieur of metabolic reprogramming: Priyakshi Kalita-de Croft

 

3:00 – 3:30pm

Afternoon tea

 

3:30 – 4:00pm

Session 3: Top Scoring Abstracts

Mark Rosenthal

 

Paper ID O04: A Randomized Phase 2 trial of Veliparib (V), Radiotherapy (RT) and Temozolomide (TMZ) in patients (pts) with unmethylated MGMT (uMGMT) Glioblastoma (GBM): Feasibility and safety outcomes (The VERTU study): Mustafa Khasraw

 

 

Paper ID O05: Picture description versus picture naming: assessing language deficits following dominant hemisphere tumour resection: Sonia Brownsett

 

 

Paper ID O06: Designing targeted therapies for glioblastomas with intratumoral heterogeneity: Seçkin Akgül

 

 

Paper ID O07: NUTMEG: A randomised Phase II study of Nivolumab and Temozolomide (TMZ) vs TMZ alone in elderly patients with newly diagnosed Glioblastoma (GBM): Trial in progress: Mustafa Khasraw

 

 

Paper ID O08: Increasing antibody theranostic uptake in primary brain tumours using focussed ultrasound: Simon Puttick

 

4:00 – 5:00pm

Session 4: COGNO and Other Trials Updates

Mark Rosenthal

 

CODEL: Liz Hovey

 

 

PersoMed-I: Liz Hovey

 

 

EX-TEM registry trial: Lucy Gately

 

 

International Trial Update: faith, hope and molecularity: Craig Gedye

 

 

Q&A

 

5:00 – 6:30pm

Welcome Reception and Poster Walkaround

 

7:30pm – late

COGNO Conference Dinner (Sky Room and Terrace, Sky Level) – includes presentation of the MSD Hubert Stuerzl Memorial Educational Award, COGNO Outreach Education Preceptorship and BTAA Lynette Williams Award

 

 

Tuesday 9 October: ASM Day 2 (P10&11 Room)

TIME

MEETING

CHAIR

8:00 8:45am

COGNO Annual General Meeting (open to COGNO members only) (P9 Room)

Anna Nowak

8:30 – 9:00am

On arrival tea/coffee

 

9:00 – 9:10am

Welcome and Day 2 program overview

Mark Pinkham

9:10 – 10:30am

Session 5: Glioma Including Plenary 4

Lucy Gately and Hamish Alexander

 

Plenary 4: Advanced Imaging for Glioma: Susan Chang

 

 

Quick Update on Histone Mutated Midline Gliomas in Adults: Mark Gilbert

 

 

Adoptive T cell therapy for GBM: David Walker

 

 

Paper ID O09: Understanding the Tumour Suppressive Function of EphrinA5 Signalling in Adult Brain Cancer: Rochelle Dsouza

 

 

Paper ID O10: Diagnostic Performance of FDG-PET/CT in the Evaluation of Glioma: Tristan Shaw

 

10:30 – 11:00am

Morning tea

 

11:00 – 12:30pm

Session 6: Survivorship and Supportive Therapies

Tamara Ownsworth

 

Using Patient Reported Outcome Measures to Improve CNS Tumour Patient Symptom Management: Terri Armstrong

 

 

Exercise Medicine for Cancer: Prue Cormie

 

 

UCSF Neuro-oncology Gordon Murray Caregiver Program: Susan Chang

 

 

Paper ID O11: Sleep disturbance among adults with primary and secondary malignant brain tumours and their caregivers: a cross-sectional study: Megan Jeon

 

 

Paper ID O12: Longitudinal health related quality of life in patients with benign and low-grade brain tumours: Lobna Alukaidey

 

 

Paper ID O13: The importance of staying connected: mediating and moderating effects of social groups on psychological wellbeing after brain tumour: Lee Cubis

 

 

Paper ID O14: What support are carers requiring over time during nurse-led support provided as part of the Care-IS study? Georgia Halkett

 

 

Panel discussion inc above speakers and Julia Robertson

 

12:30 – 1:30pm

Lunch

 

1:30 – 3:00pm

Session 7: Translational Science

Bryan Day and
Lindy Jeffree

 

A Unified Biomarker Platform for Malignant Gliomas: Erik Sulman

 

 

Targeting EGFR – Progress and Challenges: Terry Johns and Hui Gan

 

 

The Transformed Landscape of Childhood Brain Tumours: Nick Gottardo

 

 

Drivers and Passengers - Identification of Druggable Targets in Medulloblastoma: Brandon Wainwright

 

 

Paper ID O15: The EphA3 receptor is a tumour-specific therapeutic target for adult GBM and paediatric medulloblastoma: Carolin Offenhäuser

 

 

Paper ID O16: In vitro evaluation of DC vaccination combined with immune checkpoint inhibition for glioblastoma multiforme (GBM) using patient derived peripheral leucocytes: Benjamin Kong

 

 

Paper ID O17: Creating a stronger link between nanomedicine development and the clinic for the treatment of gliomas: Zachary Houston

 

 

Paper ID O18: Exploring cell cycle checkpoint inhibition and gemcitabine treatment for glioblastoma: Tracy Seymour

 

3:00 – 3:30pm

Afternoon tea

 

3:30 – 4:20pm

Session 8: Adolescent and Young Adult, Paediatric and Rare CNS Tumours

Nick Gottardo and Bryan Day

 

“Keep the pineal gland operating and you will never grow old”, Edgar Cayce: Po-ling Inglis

 

 

Are Adults just Big Kids? Tim Hassall

 

 

NCI-CONNECT: Rare adult CNS cancer project: Mark Gilbert and Terri Armstrong

 

4:20 – 4:30pm

ASM Summary and Close – includes presentation of the Most Outstanding Oral Presentation, Most Outstanding Poster Presentation and Young Investigator Awards